Radiopharm Theranostics Limited ADR (RADX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | |
| Sales | 2,353 | 196 |
| Cost of Goods | 2,328 | N/A |
| Gross Profit | 25 | 196 |
| Operating Expenses | 25,074 | 31,157 |
| Operating Income | -24,721 | -30,960 |
| Interest Expense | 42 | 422 |
| Pre-tax Income | -24,764 | -31,382 |
| Income Tax | 67 | 63 |
| Net Income Continuous | -24,831 | -31,445 |
| Net Income | $-24,831 | $-31,445 |
| EPS Basic Total Ops | -3.42 | -24.42 |
| EPS Basic Continuous Ops | -3.58 | -24.41 |
| EPS Diluted Total Ops | -3.42 | -24.42 |
| EPS Diluted Continuous Ops | -3.58 | -24.41 |
| EPS Diluted Before Non-Recurring Items | -0.01 | N/A |
| EBITDA(a) | $-23,041 | $-28,910 |